Name: Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients<br> <span style="color: #009B77">by Erin Barrett, MD</span>
Start: 2026-07-16T12:15:00-04:00
End: 2026-07-16T13:15:00-04:00
Location: Virtual (Zoom)

July 2026
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate Patients with CSU
by Andrew Mastro, PA-C

July 7 @ 12:15 pm - 1:15 pm CDT Central Time (CT)

Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate patients with CSU.
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
by Zakiya Rice, MD

July 7 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
The Dual Inhibition of IL-4 and IL-13 That Revolutionized Dermatology
by Leigh Ann Pansch, NP and Michael Payette, MD

July 7 @ 12:15 pm - 1:15 pm PDT Pacific Time (PT)

Virtual (Zoom)

Explore how IL-4 and IL-13 act as key mediators in the underlying pathophysiology of atopic dermatitis (AD), including their contribution to chronic inflammation, itch signaling, immune dysregulation, and impairment of…
A Treatment Option for Appropriate Patients With Prurigo Nodularis and Chronic Spontaneous Urticaria
by Melissa Costner, MD

July 8 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with prurigo nodularis (PN), and chronic spontaneous urticaria (CSU).
A Treatment Option for Appropriate Patients With Bullous Pemphigoid
by Erin Barrett, MD

July 8 @ 12:15 pm - 1:15 pm CDT Central Time (CT)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with bullous pemphigoid (BP).
A Treatment Option for Appropriate Patients With Atopic Dermatitis and Chronic Spontaneous Urticaria
by Brad Glick, DO

July 9 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with atopic dermatitis (AD), and chronic spontaneous urticaria (CSU).
Diagnosing and Assessing Uncontrolled Atopic Dermatitis (AD) and a Treatment Option for Appropriate Patients With Uncontrolled Moderate-to- Severe AD
by Harrison Nguyen, MD

July 9 @ 12:15 pm - 1:15 pm CDT Central Time (CT)

Virtual (Zoom)

Learn more about how to diagnose and assess uncontrolled moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients.
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
by Ahmad Amin, MD

July 9 @ 12:15 pm - 1:15 pm PDT Pacific Time (PT)

Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
by Michael Payette, MD

July 13 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
by James Song, MD

July 13 @ 12:15 pm - 1:15 pm PDT Pacific Time (PT)

Virtual (Zoom)

Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…
Diagnosing and Assessing Prurigo Nodularis (PN) and a Treatment Option for Appropriate Patients With PN
by Matthew Bruno, PA-C

July 13 @ 12:15 pm - 1:15 pm CDT Central Time (CT)

Virtual (Zoom)

Learn more about the clinical presentation and diagnostic workup of prurigo nodularis (PN) and a treatment option that may help appropriate patients.
A Treatment Option for Appropriate Patients With Prurigo Nodularis
by Heather Gates, PA-C

July 14 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with prurigo nodularis (PN).
Diagnosing and Assessing Uncontrolled Atopic Dermatitis (AD) and a Treatment Option for Appropriate Patients With Uncontrolled Moderate-to- Severe AD
by Alexandra Golant, MD

July 14 @ 12:15 pm - 1:15 pm PDT Pacific Time (PT)

Virtual (Zoom)

Learn more about how to diagnose and assess uncontrolled moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients.
A Treatment Option for Appropriate Patients With Chronic Spontaneous Urticaria
by Carsten Hamann, MD

July 15 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with chronic spontaneous urticaria (CSU).
A Treatment Option for Appropriate Patients With Atopic Dermatitis and Prurigo Nodularis
by Mona Shahriari, MD

July 15 @ 12:15 pm - 1:15 pm CDT Central Time (CT)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with atopic dermatitis (AD) and prurigo nodularis (PN).
Diagnosing and Assessing Bullous Pemphigoid (BP) and a Treatment Option for Appropriate Patients with BP
by Daniel Butler, MD

July 15 @ 12:15 pm - 1:15 pm PDT Pacific Time (PT)

Virtual (Zoom)

Learn more about the diagnosis and assessment of bullous pemphigoid (BP), including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations, and a treatment option for appropriate patients with…
A Treatment Option for Appropriate Patients With Atopic Dermatitis
by Adam Friedman, MD

July 16 @ 12:15 pm - 1:15 pm MDT Mountain Time (MT)

Virtual (Zoom)

Learn more about a treatment option that may help appropriate patients with atopic dermatitis (AD).
Type 2 Inflammation: The Story Behind the Symptoms and a Treatment Option for Appropriate Patients
by Erin Barrett, MD

July 16 @ 12:15 pm - 1:15 pm EDT Eastern Time (ET)

Virtual (Zoom)

Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU), and bullous pemphigoid (BP); which cytokines play…

July 2026